ADPT icon

Adaptive Biotechnologies

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

5% less funds holding

Funds holding: 221209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.62M
Puts
$417K
Net Calls
Net Calls Change

Top Sellers

1 -$16.5M
2 -$13.9M
3 -$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$220K
127
$217K
128
$214K
129
$213K
130
$207K
131
$205K
132
$200K
133
$198K
134
$196K
135
$193K
136
$192K
137
$175K
138
$174K
139
$173K
140
$158K
141
$155K
142
$154K
143
$151K
144
$146K
145
$146K
146
$137K
147
$119K
148
$117K
149
$115K
150
$113K